CONSIDER TAKING A PART IN A STUDY FOR
Alzheimer's Disease
If you or a loved one has been diagnosed with Alzheimer's disease, or a physician suspects it may be Alzheimer's disease, you or they may be eligible to participate in a clinical research study to help advance the treatment of Alzheimer’s.
PAVING THE WAY FOR FUTURE GENERATIONS
Your mental health is important to us
You or a loved one may qualify for a clinical study for individuals experiencing symptoms of Alzheimer's disease. You may qualify for the study, if:
You are in the age group
If you are between the ages of 50 and 87,...
Have been diagnosed
have been recently diagnosed or have a suspected clinical diagnosis of Alzheimer's disease,...
Have been vaccinated
and have been vaccinated for COVID-19 or have had a previous COVID-19 infection.*
* Other criteria may apply.
RethinkALZ and RefocusALZ Clinical Research Studies
The rethinkALZ and refocusALZ clinical research studies are currently enrolling patients. The purpose of these research studies is to learn more about the use of the study drug, simufilam, for the treatment of mild-to-moderate Alzheimer's disease. We want to test that it is safe and find out whether it can slow down disease progression and improve thinking and memory in people with Alzheimer’s disease.
PARTICIPATE IN OUR STUDY
We are now enrolling for a study for those with Alzheimer's disease
To be considered for the rethinkALZ or refocusALZ study, patients must:
- This study is for individuals who have been diagnosed with, or have suspected clinical diagnosis of, Alzheimer's disease
- Have a gradual change in memory in six months or more
- Have a family member or loved one who can be available as a study partner during the entire study
- There is no cost to enroll
- Reimbursement may be provided for study-related time and travel expenses
- You can leave the study any time
To be considered please click on the button below and fill the form.
ABOUT ARC
We take pride in our effective and efficient clinical execution.
Advanced Research Center, Inc. (ARC) is a clinical research site dedicated to administering Phase 2, 3, and 4 clinical trials. We have over 16 years of experience conducting clinical trials across various therapeutic areas, emphasizing Internal Medicine, Pediatrics, and Psychiatry/Central Nervous System.